Evogene Ltd/ IL0011050551 /
31/05/2024 21:59:41 | Var. -0.0211 | Volume | Denaro11:52:10 | Lettera11:52:10 | Max | Min |
---|---|---|---|---|---|---|
0.7450USD | -2.75% | 34,748 Fatturato: 25,070.8710 |
0.7450Quantità in denaro: 100 | 0.7639Quantità in lettera: 3,000 | 0.7749 | 0.7380 |
GlobeNewswire
14:20
Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial
GlobeNewswire
14:15
Autonomix Announces Approval of Protocol Amendment by Ethics Committee Upon Completion of All Lead-I...
GlobeNewswire
14:14
AUROBAC THERAPEUTICS Presents its R&D Strategy & Pipeline and Announces New Development Program in P...
GlobeNewswire
14:10
Maris-Tech Receives New Order for $225,000 From a Military Drone Manufacturer for a Unique Solution ...
GlobeNewswire
14:07
Four Charlesbank Portfolio Companies Named to Newsweek’s “America’s Greatest Workplaces for Mental W...
GlobeNewswire
14:05
NKGen Biotech To Present Updated Phase 1 Data on SNK02 Allogeneic NK Cell Therapy in Solid Tumors at...
GlobeNewswire
14:04
Noom Launches Noom Vibe, a Wellness Community and Habit Tracker Built for the Age of GLP-1s
GlobeNewswire
14:01
Mainz Biomed Presented Industry Leading Results of its Pooled Study at ASCO 2024
GlobeNewswire
14:00
Medicenna Reports Significant Survival Benefit in Patients with Recurrent Glioblastoma Following Tre...
GlobeNewswire
14:00
Genesis Offers New Tools and Incentives to Financial Industry Software Developers
GlobeNewswire
14:00
Denali Therapeutics Announces FDA Has Selected DNL126 (ETV:SGSH) for MPS IIIA (Sanfilippo Syndrome T...
GlobeNewswire
14:00
Core Molding Technologies to Present and Host 1x1 Meetings at the 14th Annual East Coast IDEAS Conf...